1. Home
  2. ORIS vs CING Comparison

ORIS vs CING Comparison

Compare ORIS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIS

Oriental Rise Holdings Limited Ordinary Shares

N/A

Current Price

$0.89

Market Cap

49.0M

ML Signal

N/A

CING

Cingulate Inc.

N/A

Current Price

$6.95

Market Cap

40.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ORIS
CING
Founded
2014
2012
Country
China
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.0M
40.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ORIS
CING
Price
$0.89
$6.95
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
77.3K
313.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$152.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$3.20
52 Week High
$1.87
$7.92

Technical Indicators

Market Signals
Indicator
ORIS
CING
Relative Strength Index (RSI) 38.78 59.08
Support Level $0.11 $3.58
Resistance Level $0.97 $7.92
Average True Range (ATR) 0.10 0.50
MACD -0.03 -0.01
Stochastic Oscillator 23.57 82.14

Price Performance

Historical Comparison
ORIS
CING

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: